I’ve resisted commenting on the rapid-fire news reports announced over the last couple of weeks affecting the pharmaceutical industry. Based on the past, who knows which initiative, if any, will be implemented or withdrawn? And do we really know what will develop tomorrow, or the next day, in terms of drug pricing and PBM reform? … Continue reading Chaos vs. Control